Development of a novel vesicular system using a binary mixture of sorbitan monostearate and polyethylene glycol fatty acid esters for rectal delivery of rutin

References

• Alsarra, I. A. (2009). Evaluation of proniosomes as an alternative strategy to optimize piroxicam transdermal delivery. J Microencapsul 26:272–278.
   PubMed Web of Science ®Google Scholar
• Alsarra, I. A., Bosela, A. A., Ahmed, S. M., Mahrous, G. M. (2005). Proniosomes as a drug carrier for transdermal delivery of ketorolac. Eur J Pharm Biopharm 59:485–490.
   PubMed Web of Science ®Google Scholar
• Ammar, H. O., Ghorab, M., El-Nahhas, S. A., Kamel, R. (2009). Polymeric matrix system for prolonged delivery of tramadol hydrochloride, part I: physicochemical evaluation. AAPS PharmSciTech 10:7–20.
   PubMed Web of Science ®Google Scholar
• Arunothayanun, P., Bernard, M. S., Craig, D. Q., Uchegbu, I. F., Florence, A. T. (2000). The effect of processing variables on the physical characteristics of non-ionic surfactant vesicles (niosomes) formed from a hexadecyl diglycerol ether. Int J Pharm 201:7–14.
   PubMed Web of Science ®Google Scholar
• Aungst, B. J., Rogers, N. J., Shefter, E. (1988). Comparison of nasal, rectal, buccal, sublingual and intramuscular insulin efficacy and the effects of a bile salt absorption promoter. J Pharmacol Exp Ther 244:23–27.
   PubMed Web of Science ®Google Scholar
• Baillie, A. J., Coombs, G. H., Dolan, T. F., Laurie, J. (1986). Non-ionic surfactant vesicles, niosomes, as a delivery system for the anti-leishmanial drug, sodium stibogluconate. J Pharm Pharmacol 38:502–505.
   PubMed Web of Science ®Google Scholar
• Bangham, A. D., Horne, R. W. (1964). Negative staining of phospholipids and their structural modification by surface-active agents as observed in the electron microscope. J Mol Biol 8:660–668.
   PubMed Web of Science ®Google Scholar
• Barr, W. H. Riegelman, S. (1970). Intestinal drug absorption and metabolism. I. Comparison of methods and models to study physiological factors of in vitro and in vivo intestinal absorption. J Pharm Sci 59:154–163.
   PubMed Web of Science ®Google Scholar
• Bayindir, Z. S., Yuksel, N. (2010). Characterization of niosomes prepared with various nonionic surfactants for paclitaxel oral delivery. J Pharm Sci 99:2049–2060.
   PubMed Web of Science ®Google Scholar
• Block, L. (2005). Medicated topicals. In: Beringer, P. (Ed.), Remington: the science and practice of pharmacy, 21st ed. (pp. 877–880). Philadelphia, Pennsylvania, USA: Lippincott Williams & Wilkins.
   Google Scholar
• Brandl, M. (2001). Liposomes as drug carriers: a technological approach. Biotechnol Ann Rev 7:59–85.
   PubMedGoogle Scholar
• Calabrò, M. L., Tommasini, S., Donato, P., Stancanelli, R., Raneri, D., Catania, S., et al. (2005). The rutin/beta-cyclodextrin interactions in fully aqueous solution: spectroscopic studies and biological assays. J Pharm Biomed Anal 36:1019–1027.
   PubMed Web of Science ®Google Scholar
• Cevc, G. (2004). Lipid vesicles and other colloids as drug carriers on the skin. Adv Drug Deliv Rev 56:675–711.
   PubMed Web of Science ®Google Scholar
• De Logu, A.F., A.M. Anchisi, C. Maccioni, A.M. Sinico, C. Schivo, M.L., (1997). Effects of activity of miconazole and ketoconazole in phospholipids formulations. J Antimicrob Chemother 40, 889–893.
   PubMed Web of Science ®Google Scholar
• Desai, A., Lee, M. (2007). Gibaldi’s Drug Delivery Systems in Pharmaceutical care. Chapter 7. Rectal, Vaginal and Uretheral Delivery., pp. 95–100.
   Google Scholar
• El-Laithy, H.M., Shoukry, O., Mahran, L.G. (2011). Novel sugar esters proniosomes for transdermal delivery of vinpocetine: preclinical and clinical studies. European journal of pharmaceutics and biopharmaceutics: official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 77, 43–55.
   Google Scholar
• El-Leithy, E.S., Shaker, D.S., Ghorab, M.K., Abdel-Rashid, R.S., (2010). Evaluation of mucoadhesive hydrogels loaded with diclofenac sodium-chitosan microspheres for rectal administration. AAPS PharmSciTech 11, 1695–1702.
   PubMed Web of Science ®Google Scholar
• Erjavec, V., Pavlica, Z., Sentjurc, M., Petelin, M., (2006). In vivo study of liposomes as drug carriers to oral mucosa using EPR oximetry. Int J Pharm 307, 1–8.
   PubMed Web of Science ®Google Scholar
• Fang, J.Y., Yu, S.Y., Wu, P.C., Huang, Y.B., Tsai, Y.H., (2001). In vitro skin permeation of estradiol from various proniosome formulations. Int J Pharm 215, 91–99.
   PubMed Web of Science ®Google Scholar
• Felt-Bersma, R.J., Bartelsman, J.F., (2009). Haemorrhoids, rectal prolapse, anal fissure, peri-anal fistulae and sexually transmitted diseases. Best practice & research 23, 575–592.
   PubMedGoogle Scholar
• Gohel, M., Panchal, M., Jogani, V., (2000). Novel mathematical method for quantitative expression of deviation from the Higuchi model. AAPS Pharm. Sci. Technol. 1, 43–48.
   Google Scholar
• Griffin, W.C., (1949). Classification of surface-active agents by “HLB”. J Soc Cosmetic Chem 1, 311–326.
   Google Scholar
• Heurtault, B., Saulnier, P., Pech, B., Proust, J.E., Benoit, J.P., (2003). Physico-chemical stability of colloidal lipid particles. Biomaterials 24, 4283–4300.
   PubMed Web of Science ®Google Scholar
• Hu, C., Rhodes, D.G., (1999). Proniosomes: a novel drug carrier preparation. Int J Pharm 185, 23–35.
   PubMed Web of Science ®Google Scholar
• Hu, C., Rhodes, D.G., (2000). Proniosomes: a novel drug carrier preparation. Int J Pharm 206, 110–122.
   PubMed Web of Science ®Google Scholar
• Ibrahim, M. M., Sammour, O. A., Hammad, M. A., Megrab, N. A. (2008). In vitro evaluation of proniosomes as a drug carrier for flurbiprofen. AAPS PharmSciTech 9:782–790.
   PubMed Web of Science ®Google Scholar
• Junyaprasert, V. B., Singhsa, P., Suksiriworapong, J., Chantasart, D. (2012). Physicochemical properties and skin permeation of Span 60/Tween 60 niosomes of ellagic acid. Int J Pharm 423:303–311.
   PubMed Web of Science ®Google Scholar
• Junyaprasert, V. B., Teeranachaideekul, V., Supaperm, T. (2008). Effect of charged and non-ionic membrane additives on physicochemical properties and stability of niosomes. AAPS PharmSciTech 9:851–859.
   PubMed Web of Science ®Google Scholar
• Lacy, B. E., Weiser, K. (2009). Common anorectal disorders: diagnosis and treatment. Curr Gastroenterol Rep 11:413–419.
   PubMedGoogle Scholar
• Mainardes, R. M., Urban, M. C., Cinto, P. O., Chaud, M. V., Evangelista, R. C., Gremião, M. P. (2006). Liposomes and micro/nanoparticles as colloidal carriers for nasal drug delivery. Curr Drug Deliv 3:275–285.
   PubMedGoogle Scholar
• Matsuda, H., Arima, H. (1996). Cyclodextrins in transdermal and rectal delivery. Adv Drug Deliv Rev 36:81–99.
   Google Scholar
• Miyake, K., Arima, H., Hirayama, F., Yamamoto, M., Horikawa, T., Sumiyoshi, H., et al. (2000). Improvement of solubility and oral bioavailability of rutin by complexation with 2-hydroxypropyl-beta-cyclodextrin. Pharm Dev Technol 5:399–407.
   PubMed Web of Science ®Google Scholar
• Mokhtar, M., Sammour, O. A., Hammad, M. A., Megrab, N. A. (2008). Effect of some formulation parameters on flurbiprofen encapsulation and release rates of niosomes prepared from proniosomes. Int J Pharm 361:104–111.
   PubMed Web of Science ®Google Scholar
• Nakada, Y., Awata, N., Ikuta, Y., Goto, S. (1989). The effect of bile salts on the oral mucosal absorption of human calcitonin in rats. J Pharmacobiodyn 12:736–743.
   PubMedGoogle Scholar
• Nasr, M. (2010). In vitro and in vivo evaluation of proniosomes containing celecoxib for oral administration. AAPS PharmSciTech 11:85–89.
   PubMed Web of Science ®Google Scholar
• Patel, D. M., Patel, N. M., Patel, V. F., Bhatt, D. A. (2007). Floating granules of ranitidine hydrochloride-gelucire 43/01: formulation optimization using factorial design. AAPS PharmSciTech 8: Article 30.
   Web of Science ®Google Scholar
• Perrett, S., Golding, M., Williams, W. P. (1991). A simple method for the preparation of liposomes for pharmaceutical applications: characterization of the liposomes. J Pharm Pharmacol 43:154–161.
   PubMed Web of Science ®Google Scholar
• Shahiwala, A., Misra, A. (2002). Studies in topical application of niosomally entrapped Nimesulide. J Pharm Pharm Sci 5:220–225.
   PubMed Web of Science ®Google Scholar
• Shaikh, K. S., Chellampillai, B., Pawar, A. P. (2010). Studies on nonionic surfactant bilayer vesicles of ciclopirox olamine. Drug Dev Ind Pharm 36:946–953.
   PubMed Web of Science ®Google Scholar
• Siegel, I. A., Gordon, H. P. (1985). Effects of surfactants on the permeability of canine oral mucosa in vitro. Toxicol Lett 26:153–158.
   PubMed Web of Science ®Google Scholar
• Solanki, A. B., Parikh, J. R., Parikh, R. H. (2007). Formulation and optimization of piroxicam proniosomes by 3-factor, 3-level Box-Behnken design. AAPS PharmSciTech 8:E86.
   PubMedGoogle Scholar
• Uchegbu, I. F., Florence, A. T. (1995). Non-ionic surfactant vesicles (niosomes): physical and pharmaceutical chemistry. Adv Coll Interf Sci 58:1–55.
   Web of Science ®Google Scholar
• Uchegbu, I. F., Vyas, S. P. (1998). Non-ionic surfactant based vesicles (niosomes) in drug delivery. Int J Pharm 172:33–70.
   Web of Science ®Google Scholar
• Vora, B., Khopade, A. J., Jain, N. K. (1998). Proniosome based transdermal delivery of levonorgestrel for effective contraception. J Control Release 54:149–165.
   PubMed Web of Science ®Google Scholar
• Yonezawa, Y., Ishida, S., Sunada, H. (2001). Release from or through a wax matrix system. I. Basic release properties of the wax matrix system. Chem Pharm Bull 49:1448–1451.
   PubMed Web of Science ®Google Scholar
• Yoshioka, T., Sternberg, B., Florence, A. T. (1994). Preparation and properties of vesicles (niosomes) of sorbitan monoesters (Span 20, 40, 60, and 80) and a sorbitan triester (Span 85). Int J Pharm 105:1–6.
   Web of Science ®Google Scholar